High-res insights into key bacterial enzyme could lead to development of new antibiotics

FHS
June 30, 2023
7:41 pm

A team of scientists from around the globe, including those from Trinity College Dublin, has gained high-res structural insights into a key bacterial enzyme, which may help chemists design new drugs to inhibit it and thus suppress disease-causing bacteria.

BioAge Labs scraps Phase 2 obesity trial just months after IPO

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 7, 2024

The evidence grows: Prices spike after mergers between far-flung hospitals

The trend is clear: When hospitals in the same community merge, prices spike. The government has such an easy time blocking those deals, hospitals rarely

April 23, 2024

J&J’s Janssen nabs new indication, full approval for cancer drug Rybrevant

Johnson & Johnson’s Janssen on Friday earned an FDA approval for its cancer drug Rybrevant (amivantamab-vmjw) for the first-line treatment of locally advanced or metastatic

March 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.